Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
|---|---|---|---|
| Revenue | 10.76B | 9.07B | 6.48B |
| Cost of revenue | 8.10B | 7.46B | 5.36B |
| Gross profit | 2.66B | 1.61B | 1.11B |
| Research and development | 35M | 50M | 117M |
| Selling, general and administrative | 269M | 275M | 296M |
| Operating income | 2.25B | −9M | 222M |
| Income tax | 584M | 205M | 237M |
| Net income | 1.07B | 283M | 2.31B |
| Earnings per share | 2.84 | 0.79 | 4.65 |
| Earnings per share, diluted | 2.83 | 0.78 | 4.59 |
| Weighted average shares | 494M | 516M | 518M |
| Metric | 18 Aug 2026 | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 |
|---|---|---|---|---|---|
| Cash and equivalents | — | 5.01B | 7.59B | 744M | 1.88B |
| Receivables | — | 2.56B | 1.66B | 2.10B | — |
| Inventory | — | 2.75B |
| Metric | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
|---|---|---|---|
| Operating cash flow | 1.48B | 2.79B | 4.08B |
| Depreciation and amortisation | 1.76B | 1.73B | 925M |
| Capital expenditure | 1.84B | 2.26B | 3.89B |
| Investing cash flow | −1.91B | 6.17B | −4.76B |
| Financing cash flow |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 2.60B |
| 2.95B |
| — |
| Current assets | — | 11.16B | 12.57B | 6.47B | — |
| Goodwill | — | 421M | 442M | 1.11B | — |
| Total assets | — | 45.44B | 47.04B | 56.19B | — |
| Current liabilities | — | 4.40B | 4.37B | 5.89B | — |
| Short-term debt | — | 403M | 423M | 515M | — |
| Long-term debt | — | 3.50B | 4.11B | 6.02B | — |
| Total liabilities | — | 19.43B | 19.94B | 27.90B | — |
| Equity | — | 26.01B | 27.10B | 28.29B | — |
| Shares outstanding | — | 489M | 506M | 517M | — |
| −1.85B |
| −2.57B |
| −469M |